Parkinson's Disease Clinical Trial
Official title:
Mindfulness Based Intervention (MBI) on the Quality of Life and Non-Motor Symptoms (NMS) of Persons With Parkinson's Disease (PD)
Scientific Abstract:
The investigators propose a study to examine the impact of a Mindfulness Based Intervention
(MBI) on the quality of life and Non-Motor Symptoms (NMS) of persons with Parkinson's
disease (PD).
NMS add significantly to the disease burden and negatively impact the quality of life in PD
(1,2). In a previous study the investigators confirmed the high prevalence of NMS in PD
patients with either early- or late-onset of disease (3). Despite currently available
treatments, PD leads to worsening disability and there remains a need for new approaches. A
Mindfulness Based Intervention may provide an important adjuvant therapy in the treatment of
PD in relation to NMS and quality of life.
A minimum of 100 patients will be randomly assigned to the MBI or 'Treatment As Usual' (TAU)
groups. Clinical assessments (motor and non-motor scores) will be performed in both groups.
The TAU group will be offered MBI after completion of the study.
To the best of our knowledge, this is the first large scale study using MBI in this
indication.
The investigators propose a study to examine the impact of a Mindfulness Based Intervention
(MBI) on the quality of life and Non-Motor Symptoms (NMS) of persons with Parkinson's
disease (PD).
NMS add significantly to the disease burden and negatively impact the quality of life in PD
(1,2). In a previous study the investigators confirmed the high prevalence of NMS in PD
patients with either early- or late-onset of disease (3). Despite currently available
treatments, PD leads to worsening disability and there remains a need for new approaches. A
Mindfulness Based Intervention may provide an important adjuvant therapy in the treatment of
PD in relation to NMS and quality of life.
A minimum of 100 patients will be randomly assigned to the MBI or 'Treatment As Usual' (TAU)
groups. Clinical assessments (motor and non-motor scores) will be performed in both groups.
The TAU group will be offered MBI after completion of the study.
To the best of our knowledge, this is the first large scale study using MBI in this
indication.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
| Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
| Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
| Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
| Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
| Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
| Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
| Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
| Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
| Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
| Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
| Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
| Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
| Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
| Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
| Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
| Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
| Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
| Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
| Completed |
NCT02874274 -
Vaccination Uptake (VAX) in PD
|
N/A |